UPDATE : Friday, March 23, 2018
Patents on cancer biomarker kit increase at fast pace
Patents related to cancer biomarker kit, also known as an in-vitro diagnost...
by Lee Han-soo  |  2017-10-10 17:44
CJ Healthcare, YL Biologics signs technology transfer agreement
CJ Healthcare said Thursday that it has signed an agreement with YL Biologi...
by Lee Han-soo  |  2017-09-28 15:01
LegoChem, Geom Therapeutics signs technology transfer accord
LegoChem Bioscience said Wednesday that it has signed an agreement with Geo...
by Lee Han-soo  |  2017-09-27 17:52
Aprogen’s rheumatoid arthritis biosimilar wins sales approval in Japan
Aprogen Pharmaceuticals said Wednesday that the company’s NI-071 (Original:...
by Lee Han-soo  |  2017-09-27 17:45
Celltrion will use Oracle Health platform to streamline processes
Celltrion will use Oracle Health platforms to help streamline regulatory re...
by Marian Chu  |  2017-09-27 10:47
Can Celltrion, Samsung make stable earnings with biosimilar?
Amid the intensifying competition to lower drug prices, market watchers pre...
by Nam Doo-hyun  |  2017-09-26 17:31
Medifron aims high through R&D
Medifron said Friday that it would increase its capital by issuing new stoc...
by Lee Han-soo  |  2017-09-25 16:19
Korea lags far behind in biomedical R&D: report
Korea’s investment in the biomedical research and development lags far behi...
by Nam Doo-hyun  |  2017-09-21 16:14
Biosimilar prescriptions fall by the wayside in Korea
Biosimilar uptake in the Korean market has been dismal, according to data a...
by Marian Chu  |  2017-09-21 14:56
Samsung Bioepis gets additional approval for its biosimilar
Amid the controversy caused by MSD Korea’s alleged decision to cease promot...
by Lee Hye-seon  |  2017-09-21 12:03
MSD dissolves promotion team for Samsung Bioepis’ biosimilars
MSD Korea has dissolved its Samsung Bioepis’s biosimilar promotion team and...
by Lee Han-soo  |  2017-09-21 11:58
Sillajen emerges as biggest beneficiary of preferential listing
Sillajen has emerged as the most successful case of the preferential listin...
by Nam Doo-hyun  |  2017-09-20 17:22
Samsung Bioepis gets nods for phase 3 trials to treat macular degeneration
Samsung Bioepis said Tuesday that it has received Ministry of Food and Drug...
by Lee Han-soo  |  2017-09-19 17:39
Korean biopharmaceutical industry ranked 2nd among emerging countries
The Korean biopharmaceutical industry ranked second only to Singapore regar...
by Marian Chu  |  2017-09-19 10:37
EU approvals for Samsung Bioepis push up share prices
Investors are showing higher expectation for Samsung Bioepis, a Samsung Gro...
by Nam Doo-hyun  |  2017-09-18 14:45
Genexin, Handok presents persistent growth hormone clinical trial results
Genexin and Handok have announced the intermediate results of phase 2 clini...
by Lee Han-soo  |  2017-09-18 14:39
Celltrion in controversy over sexual harassment case
Celltrion found itself embroiled in a controversial situation afters CEO Se...
by Lee Han-soo  |  2017-09-15 18:11
‘Knowledge’ is core ability for bio industrialists, survey says
“Knowledge” is the most important element for people engaged in bio and hea...
by Nam Doo-hyun  |  2017-09-15 16:28
Access Bio, PFSCM sign supply agreement for malaria kit
Access Bio said Friday that it has signed a supply agreement of partnership...
by Lee Han-soo  |  2017-09-15 14:52
‘BIOplus Incheon 2017’ shares product-developing know-how
BIOplus Incheon 2017 successfully finished their second annual global confe...
by Lee Han-soo  |  2017-09-14 11:14
Back to Top